This research is being done because extensive preclinical research conducted by the member of the Inovium Scientific Advisory Board in Athens, Greece has shown strong evidence to support the efficacy of the treatment for these purposes, and has already resulted in the resumption of menses, hormone stabilization, and successful IVF, pregnancy, and conception in multiple women using only natural cycle IVF, with no stimulation. The use of stimulation (gonadotropins) and targeted pre- and posttreatment hormone monitoring within the Inovium trials is designed to optimize the successful transition of the patient from the initial treatment to IVF, pregnancy, and conception.